Publications by authors named "Fabio Da Roit"

Claim this Profile
I
Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy.
Fabio Da Roit, Patrick J Engelberts, Ronald P Taylor, Esther C W Breij, Giuseppe Gritti

Haematologica· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab.
Josée Golay, Fabio Da Roit, Luca Bologna, Claudia Ferrara, Jeanette H Leusen

Blood· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ofatumumab is more efficient than rituximab in lysing B chronic lymphocytic leukemia cells in whole blood and in combination with chemotherapy.
Luca Bologna, Elisa Gotti, Fabio Da Roit, Tamara Intermesoli, Alessandro Rambaldi

J Immunol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis